Dr Gael Morrow g.morrow1@rgu.ac.uk
Chancellor's Fellow
Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1).
Morrow, Gael B.; Mutch, Nicola J.
Authors
Nicola J. Mutch
Abstract
Plasminogen activator inhibitor 1 (PAI-1), a SERPIN inhibitor, is primarily known for its regulation of fibrinolysis. However, it is now known that this inhibitor functions and contributes to many (patho)physiological processes including inflammation, wound healing, cell adhesion, and tumor progression. This review discusses the past, present, and future roles of PAI-1, with a particular focus on the discovery of this inhibitor in the 1970s and subsequent characterization in health and disease. Throughout the past few decades diverse functions of this serpin have unraveled and it is now considered an important player in many disease processes. PAI-1 is expressed by numerous cell types, including megakaryocytes and platelets, adipocytes, endothelial cells, hepatocytes, and smooth muscle cells. In the circulation PAI-1 exists in two pools, within plasma itself and in platelet α-granules. Platelet PAI-1 is secreted following activation with retention of the inhibitor on the activated platelet membrane. Furthermore, these anucleate cells contain PAI-1 messenger ribonucleic acid to allow de novo synthesis. Outside of the traditional role of PAI-1 in fibrinolysis, this serpin has also been identified to play important roles in metabolic syndrome, obesity, diabetes, and most recently, acute respiratory distress syndrome, including coronavirus disease 2019 disease. This review highlights the complexity of PAI-1 and the requirement to ascertain a better understanding on how this complex serpin functions in (patho)physiological processes.
Citation
MORROW, G.B. and MUTCH, N.J. 2023. Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1). Seminars in thrombosis and hemostasis [online], 49(3), pages 305-313. Available from: https://doi.org/10.1055/s-0042-1758791
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 15, 2022 |
Online Publication Date | Dec 15, 2022 |
Publication Date | Apr 30, 2023 |
Deposit Date | Aug 4, 2023 |
Publicly Available Date | Dec 16, 2023 |
Journal | Seminars in thrombosis and hemostasis |
Print ISSN | 0094-6176 |
Electronic ISSN | 1098-9064 |
Publisher | Thieme Gruppe |
Peer Reviewed | Peer Reviewed |
Volume | 49 |
Issue | 3 |
Pages | 305-313 |
DOI | https://doi.org/10.1055/s-0042-1758791 |
Keywords | PAI-1; Thrombosis; ARDS; Obesity; Metabolic syndrome |
Public URL | https://rgu-repository.worktribe.com/output/2010397 |
Files
MORROW 2023 Past present and future (AAM)
(1.4 Mb)
PDF
Copyright Statement
© 2022. Thieme. All rights reserved.
You might also like
The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1.
(2022)
Journal Article
Downloadable Citations
About OpenAIR@RGU
Administrator e-mail: publications@rgu.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search